Ennov announces its inclusion in the 2018 “Market Guide for Quality Management System Software”, published by Gartner, Inc., the leading information technology research and advisory company.
According to Gartner,
“Organizations today are recognizing that proprietary QMS software and their custom-made approaches to quality management are antiquated, insufficient and in need of an overhaul. Additionally, many organizations do not have any QMS solutions in place at all, and struggle to understand the offerings of competing vendors in the marketplace.”
According to Ennov CEO Olivier Pâris,
“Ennov is honored to be named by Gartner as a Representative Vendor in the Market Guide for Quality Management System Software. We have been providing our innovative QMS software to our clients for many years now and it is very rewarding to be recognized by such a well-respected source for our contributions to the industry.”
Positioned to address regulatory and FDA requirements, such as 21 CFR Part 11, Ennov’s QMS suite is built on its unified compliance platform which, in addition to quality management, also provides solutions for regulatory affairs, clinical trials and pharmacovigilance.
Ennov’s QMS functionality includes support for non-conformances & CAPAs, change controls, audits, deviations, claims and many other quality processes. Integrated document and learning management modules complete the software suite and provide a comprehensive solution to the most demanding QMS requirements.
Ennov’s QMS software is currently being used by over 80 Life Science companies worldwide.
Gartner, “Market Guide for Quality Management System Software,”
Analysts: Sam New | Simon F. Jacobson
Published: 14 August 2018
Headquartered in Paris, with offices in San Jose, CA and Cambridge, UK, Ennov provides the most cost effective, comprehensive and user-friendly solutions for regulated content and process management for the Life Sciences industry. Our suite of software solutions is built on our unified compliance platform and is being used by over 150 Life Sciences companies and more than 250,00 users worldwide.